Welcome to our dedicated page for CONVATEC GRP PLC UNSP/ADR news (Ticker: CNVVY), a resource for investors and traders seeking the latest updates and insights on CONVATEC GRP PLC UNSP/ADR stock.
Convatec is a global medical products and technologies company that specializes in wound therapeutics, ostomy care, continence, and critical care, as well as infusion devices. The company's products offer various clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes, and reduced total cost of care. Some of Convatec's well-known brands include Aquacel® advanced wound dressings, which create an optimal healing environment by forming a gel when in contact with wound fluid. With over 9,000 employees and 11 manufacturing sites in 8 countries, Convatec operates in more than 100 countries. The company is owned by Nordic Capital and Avista Capital Partners.
Convatec has announced that the FDA has cleared its InnovaBurn® placental extracellular matrix medical device for the management of complex surgical wounds and burns, particularly partial-thickness second-degree burns. This device is part of Convatec's InnovaMatrix® platform, representing a significant advancement in ECM technology. The InnovaBurn® device is ready for commercial use, featuring unique sizing and ease of application, which can enhance patient access to advanced treatment options. Approximately 500,000 individuals seek medical treatment for burns each year; thus, this innovative solution aligns with unmet clinical needs in wound management.
Convatec has received FDA clearance for its InnovaMatrix® PD particulate placental extracellular matrix medical device, marking it as the first of its kind for wound management. This innovative device is designed specifically for managing complex surgical wounds, chronic stalled wounds, and burns. Joining Convatec's existing InnovaMatrix® AC product, it provides physicians with a reliable tool that replaces older human-derived products no longer available. The device requires no preparation or special storage, leveraging Convatec's TriCleanse™ technology for enhanced safety and effectiveness in healing.